Home NDC 44567-237 Ceftazidime
Product NDC 44567-237
11-digit product format 445670237
Labeler code 44567
Product ID 44567-237_a225696b-a8e8-45cc-a329-9f312e03ea1a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ceftazidime
Dosage form INJECTION, POWDER, FOR SOLUTION
Route INTRAVENOUS
Labeler WG Critical Care, LLC
Application ANDA062640
Marketing category ANDA
Marketing start 2013-01-31
Substance CEFTAZIDIME
Active strength 6 g/100mL
Pharmacologic classes Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A062640-001 CEFTAZIDIME CEFTAZIDIME 500MG/VIAL INJECTABLE / INJECTION 1985-11-20 A062640-002 CEFTAZIDIME CEFTAZIDIME 1GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 A062640-003 CEFTAZIDIME CEFTAZIDIME 2GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 A062640-004 CEFTAZIDIME CEFTAZIDIME 6GM/VIAL INJECTABLE / INJECTION AP RS 1992-02-03
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A062640-001 CEFTAZIDIME 500MG/VIAL INJECTABLE / INJECTION 1985-11-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A062640-002 CEFTAZIDIME 1GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A062640-003 CEFTAZIDIME 2GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A062640-004 CEFTAZIDIME 6GM/VIAL INJECTABLE / INJECTION AP RS 1992-02-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062640-001 CEFTAZIDIME 500MG/VIAL INJECTABLE / INJECTION 1985-11-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062640-002 CEFTAZIDIME 1GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062640-003 CEFTAZIDIME 2GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062640-004 CEFTAZIDIME 6GM/VIAL INJECTABLE / INJECTION AP RS 1992-02-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A062640-001 CEFTAZIDIME 500MG/VIAL INJECTABLE / INJECTION 1985-11-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A062640-002 CEFTAZIDIME 1GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A062640-003 CEFTAZIDIME 2GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A062640-004 CEFTAZIDIME 6GM/VIAL INJECTABLE / INJECTION AP RS 1992-02-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062640-001 CEFTAZIDIME 500MG/VIAL INJECTABLE / INJECTION 1985-11-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062640-002 CEFTAZIDIME 1GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062640-003 CEFTAZIDIME 2GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062640-004 CEFTAZIDIME 6GM/VIAL INJECTABLE / INJECTION AP RS 1992-02-03 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062640-001 CEFTAZIDIME 500MG/VIAL INJECTABLE / INJECTION 1985-11-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062640-002 CEFTAZIDIME 1GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062640-003 CEFTAZIDIME 2GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062640-004 CEFTAZIDIME 6GM/VIAL INJECTABLE / INJECTION AP RS 1992-02-03 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062640-001 CEFTAZIDIME 500MG/VIAL INJECTABLE / INJECTION 1985-11-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062640-002 CEFTAZIDIME 1GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062640-003 CEFTAZIDIME 2GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062640-004 CEFTAZIDIME 6GM/VIAL INJECTABLE / INJECTION AP RS 1992-02-03 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062640-001 CEFTAZIDIME 500MG/VIAL INJECTABLE / INJECTION 1985-11-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062640-002 CEFTAZIDIME 1GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062640-003 CEFTAZIDIME 2GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062640-004 CEFTAZIDIME 6GM/VIAL INJECTABLE / INJECTION AP RS 1992-02-03 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062640-001 CEFTAZIDIME 500MG/VIAL INJECTABLE / INJECTION 1985-11-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062640-002 CEFTAZIDIME 1GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062640-003 CEFTAZIDIME 2GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062640-004 CEFTAZIDIME 6GM/VIAL INJECTABLE / INJECTION AP RS 1992-02-03 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062640-001 CEFTAZIDIME 500MG/VIAL INJECTABLE / INJECTION 1985-11-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062640-002 CEFTAZIDIME 1GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062640-003 CEFTAZIDIME 2GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062640-004 CEFTAZIDIME 6GM/VIAL INJECTABLE / INJECTION AP RS 1992-02-03 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A062640-001 CEFTAZIDIME 500MG/VIAL INJECTABLE / INJECTION 1985-11-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A062640-002 CEFTAZIDIME 1GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A062640-003 CEFTAZIDIME 2GM/VIAL INJECTABLE / INJECTION AP RS 1985-11-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A062640-004 CEFTAZIDIME 6GM/VIAL INJECTABLE / INJECTION AP RS 1992-02-03 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Ceftazidime
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CEFTAZIDIME 6 g/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 9M416Z9QNR Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 242800 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 44567-237-06 Ceftazidime 6 in 1 CARTON INJECTION, POWDER, FOR SOLUTION 6 8 44567-237-06 Ceftazidime 100 mL in 1 VIAL INJECTION, POWDER, FOR SOLUTION 100 8
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 44567-237 CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC] 8 Current NDC, Legacy NDC, 2 package rows 20210924_22d6534c-4488-48a1-8d78-e2fb908259de.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 44567-237-06 44567023706 6 VIAL in 1 CARTON (44567-237-06) / 100 mL in 1 VIAL 6 vial 2013-01-31 0000-00-00 No No Current